Video yükleniyor...

Video Yüklenemedi

Bu video yüklenirken bir sorun oluştu. Bu geçici bir ağ sorunundan kaynaklanıyor olabilir veya video kullanılamıyor olabilir.

Ana Sayfaya Dön

🚨 BREAKING: Scientists in China grew brain cells in a lab, implanted them into Parkinson's patients, and saw real dopamine come back. Now the FDA has approved this therapy for Phase 1 in the US. This is XS-411. And it might be the most important stem cell story you... show more

Harshi Peiris, Ph.D.

8,343 subscribers

53,392 görüntüleme • 3 ay önce •via X (Twitter)

Anya Rossi• Live Now

Private livecam show

0 Yorum

Yorum bulunmuyor

Orijinal gönderinin yorumları burada görünecek

Benzer Videolar

🚨 BREAKING: Scientists just delivered a gene into human brains that could PREVENT Alzheimer's in the highest-risk people on Earth. Phase 1 trial. 15 patients. Zero serious side effects. And it WORKED. Thread 🧵👇

🚨 BREAKING: Scientists just delivered a gene into human brains that could PREVENT Alzheimer's in the highest-risk people on Earth. Phase 1 trial. 15 patients. Zero serious side effects. And it WORKED. Thread 🧵👇

Harshi Peiris, Ph.D.

22,319 görüntüleme • 2 ay önce

🚨 BREAKING: Scientists used gene therapy to make heavy-drinking monkeys almost completely stop drinking. The protein responsible? Your brain already makes it. It protects dopamine neurons. And most people have never heard of it. It's called GDNF. Thread 🧵

🚨 BREAKING: Scientists used gene therapy to make heavy-drinking monkeys almost completely stop drinking. The protein responsible? Your brain already makes it. It protects dopamine neurons. And most people have never heard of it. It's called GDNF. Thread 🧵

Harshi Peiris, Ph.D.

19,708 görüntüleme • 2 ay önce

BREAKING: Scientists just ran the first-ever clinical trial of creatine in Alzheimer’s patients. Brain creatine went up. Memory and thinking improved. But the same supplement FAILED a 5-year, 1,741-patient Parkinson’s trial in 2015. What changed? What does this mean for brain energy? A thread on the most fascinating story in brain energy research right now. 🧵🧪 #Alzheimers #Parkinsons #Creatine

BREAKING: Scientists just ran the first-ever clinical trial of creatine in Alzheimer’s patients. Brain creatine went up. Memory and thinking improved. But the same supplement FAILED a 5-year, 1,741-patient Parkinson’s trial in 2015. What changed? What does this mean for brain energy? A thread on the most fascinating story in brain energy research right now. 🧵🧪 #Alzheimers #Parkinsons #Creatine

Harshi Peiris, Ph.D.

64,647 görüntüleme • 1 ay önce

Scientists just figured out how to reverse aging using AI. And this is a massive breakthrough. We can now reprogram any human cell back to age 20. Heart cells, brain cells, skin cells, all reset to their biological prime. And here’s the wildest part…the technology to do this, has already existed since 2012 (it won the Nobel Prize). But the real breakthrough wasn’t possible until this year, when they supercharged it with AI. It’s a wild story. So in 2006, scientists discovered Yamanaka factors. They’re proteins that can basically convert any normal cell into a universal stem cell. Now this was a huge deal, because these stem cells are basically like magic healers. If you have torn muscle tissue, you could inject these stem cells into the area and they will turn into the youthful muscle cells you need. So Yamanaka factors were this insane breakthrough, because they allowed any human to turn any cell you already have into these magic healers. But, there was one big problem… It turns out, the original Yamanaka factors weren’t very good at this stem cell conversion. They could do it, but they just weren’t very reliable. Enter OpenAI...and this is where things get crazy. OpenAI designed a special AI model built specifically to create new proteins. Think of it like ChatGPT but for protein engineering. So they took all the Yamanaka research and asked this new AI to go ham on improving it. And get this… Their version was 50x more effective than the original. They tested it on 50 year old cells and it successfully started repairing 30% of their cells in just 7 days. This is just science fiction…it actually happened. And it sounds crazy, but in a few years, humans will be able to take a shot that will literally reverse the age of their cells.

Scientists just figured out how to reverse aging using AI. And this is a massive breakthrough. We can now reprogram any human cell back to age 20. Heart cells, brain cells, skin cells, all reset to their biological prime. And here’s the wildest part…the technology to do this, has already existed since 2012 (it won the Nobel Prize). But the real breakthrough wasn’t possible until this year, when they supercharged it with AI. It’s a wild story. So in 2006, scientists discovered Yamanaka factors. They’re proteins that can basically convert any normal cell into a universal stem cell. Now this was a huge deal, because these stem cells are basically like magic healers. If you have torn muscle tissue, you could inject these stem cells into the area and they will turn into the youthful muscle cells you need. So Yamanaka factors were this insane breakthrough, because they allowed any human to turn any cell you already have into these magic healers. But, there was one big problem… It turns out, the original Yamanaka factors weren’t very good at this stem cell conversion. They could do it, but they just weren’t very reliable. Enter OpenAI...and this is where things get crazy. OpenAI designed a special AI model built specifically to create new proteins. Think of it like ChatGPT but for protein engineering. So they took all the Yamanaka research and asked this new AI to go ham on improving it. And get this… Their version was 50x more effective than the original. They tested it on 50 year old cells and it successfully started repairing 30% of their cells in just 7 days. This is just science fiction…it actually happened. And it sounds crazy, but in a few years, humans will be able to take a shot that will literally reverse the age of their cells.

Whiplash347

68,643 görüntüleme • 8 ay önce

🚨 BREAKING: Parkinson's disease may begin in your GUT — not your brain. Peer-reviewed science now shows gut changes can precede motor symptoms by 10–20 YEARS. And a deficiency in specific B vitamins may be driving the damage. Thread 🧵👇

🚨 BREAKING: Parkinson's disease may begin in your GUT — not your brain. Peer-reviewed science now shows gut changes can precede motor symptoms by 10–20 YEARS. And a deficiency in specific B vitamins may be driving the damage. Thread 🧵👇

Harshi Peiris, Ph.D.

15,923 görüntüleme • 1 ay önce

Remember Aduhelm? It was Biogen’s $56,000/year Alzheimer’s drug that didn’t even work. Worse, it caused brain swelling, brain bleeding, and sudden falls in patients—and the FDA approved it anyway. But the truth is, you don’t need deep pockets to treat Alzheimer’s. You just need to look at what Big Pharma can’t monetize. This report exposes the real causes behind Alzheimer’s—and the cheap treatment options you should explore instead. 🧵 THREAD

Remember Aduhelm? It was Biogen’s $56,000/year Alzheimer’s drug that didn’t even work. Worse, it caused brain swelling, brain bleeding, and sudden falls in patients—and the FDA approved it anyway. But the truth is, you don’t need deep pockets to treat Alzheimer’s. You just need to look at what Big Pharma can’t monetize. This report exposes the real causes behind Alzheimer’s—and the cheap treatment options you should explore instead. 🧵 THREAD

The Vigilant Fox 🦊

137,431 görüntüleme • 7 ay önce

🔴Promising new data: Red light therapy is showing real results in Parkinson's disease clinical trials — gait improves, tremors ease, and new brain imaging suggests it may actually protect dopamine neurons. This isn't fringe science. It's peer-reviewed. Here's what the data shows 🧵👇 #Parkinsons #NeurologyResearch

🔴Promising new data: Red light therapy is showing real results in Parkinson's disease clinical trials — gait improves, tremors ease, and new brain imaging suggests it may actually protect dopamine neurons. This isn't fringe science. It's peer-reviewed. Here's what the data shows 🧵👇 #Parkinsons #NeurologyResearch

Harshi Peiris, Ph.D.

35,223 görüntüleme • 1 ay önce

GREAT NEWS for the vaccine-injured in Japan… “This is life-changing…I have my life back…” Japan is HEALING vaccine-injured patients with DFPP + stem cell therapy. Dr. Mary Bowden has already sent 2 patients who got their lives back. THANK YOU 🙏🏻

GREAT NEWS for the vaccine-injured in Japan… “This is life-changing…I have my life back…” Japan is HEALING vaccine-injured patients with DFPP + stem cell therapy. Dr. Mary Bowden has already sent 2 patients who got their lives back. THANK YOU 🙏🏻

Liz Churchill

981,998 görüntüleme • 3 ay önce

A whole new wave of disease therapies have started to arrive. They're based on lab made stem cells that can reprogram the body. Folks like Jeff Bezos, Sam Altman and Brian Armstrong have invested billions of dollars into this technology. @nabsicle is trying to mass produce these new stem cells to make the therapies cheaper and more widespread. This is our full episode with her where we get deep into iPSCs and how this technology works. The Core Memory podcast is on all major platforms and on YouTube down below. Brex and @e1ventures are very smart and help us bring the world's smartest podcast to you. Enjoy! Timestamps 00:00 Intro 01:22 Cell Rejuvenation 02:30 AI and Biotech 06:18 Lab-Made vs Natural Stem Cells 08:25 Programming Cell States 10:07 Reversing Parkinson's 12:15 Japan’s Stem Cell Trials 16:46 Personalized Cells 21:19 Cellino’s Laser Bubble Technology 31:34 Stem Cell Fabs 38:33 Personalized Medicine 43:02 Lowering Stem Cell Therapy Costs 46:31 Can Humans Live Forever?

A whole new wave of disease therapies have started to arrive. They're based on lab made stem cells that can reprogram the body. Folks like Jeff Bezos, Sam Altman and Brian Armstrong have invested billions of dollars into this technology. @nabsicle is trying to mass produce these new stem cells to make the therapies cheaper and more widespread. This is our full episode with her where we get deep into iPSCs and how this technology works. The Core Memory podcast is on all major platforms and on YouTube down below. Brex and @e1ventures are very smart and help us bring the world's smartest podcast to you. Enjoy! Timestamps 00:00 Intro 01:22 Cell Rejuvenation 02:30 AI and Biotech 06:18 Lab-Made vs Natural Stem Cells 08:25 Programming Cell States 10:07 Reversing Parkinson's 12:15 Japan’s Stem Cell Trials 16:46 Personalized Cells 21:19 Cellino’s Laser Bubble Technology 31:34 Stem Cell Fabs 38:33 Personalized Medicine 43:02 Lowering Stem Cell Therapy Costs 46:31 Can Humans Live Forever?

Ashlee Vance

21,622 görüntüleme • 4 ay önce

Breakthrough Update: Today, Vertex announced that they are beginning their Phase 3, or pivotal trial for VX-880, a stem cell-derived islet therapy. A pivotal trial gathers the data required for an FDA submission. This therapy is for people with type 1 diabetes (T1D) and hypoglycemia unawareness and severe hypoglycemic episodes. This is a HUGE first for the #T1D community as it is the first time a scalable cure for some people with T1D is entering this phase. Breakthrough T1D and the T1D Fund are incredibly proud to have supported this work in cell therapies—a top priority for our organization. We want to congratulate our partners at Vertex and thank all the patients who have participated in clinical trials. Your courage and commitment are inspiring. Learn more here:

Breakthrough Update: Today, Vertex announced that they are beginning their Phase 3, or pivotal trial for VX-880, a stem cell-derived islet therapy. A pivotal trial gathers the data required for an FDA submission. This therapy is for people with type 1 diabetes (T1D) and hypoglycemia unawareness and severe hypoglycemic episodes. This is a HUGE first for the #T1D community as it is the first time a scalable cure for some people with T1D is entering this phase. Breakthrough T1D and the T1D Fund are incredibly proud to have supported this work in cell therapies—a top priority for our organization. We want to congratulate our partners at Vertex and thank all the patients who have participated in clinical trials. Your courage and commitment are inspiring. Learn more here:

Breakthrough T1D

42,448 görüntüleme • 1 yıl önce

🚨WOW! The FDA’s new and promising initiative - regulatory flexibilities for Cell and Gene therapies, is a direct result of the recent Cell & Gene Therapy Roundtable 🧵👇 that was hosted 6 months ago by FDA commissioner Dr. Marty Makary and the director of the FDA’s Center for Biologics Evaluation and Research (CBER) Vinay Prasad MD MPH, in which top industry leaders and scientists shared their views about how to accelerate the R&D process and innovation in the 🇺🇸 BioTech and Pharma ecosystem. It is great to see that this important meeting bore fruit and helped not only to shape the future of the American BioTech ecosystem for years to come but also provided huge hope for patients with genetic diseases worldwide!

🚨WOW! The FDA’s new and promising initiative - regulatory flexibilities for Cell and Gene therapies, is a direct result of the recent Cell & Gene Therapy Roundtable 🧵👇 that was hosted 6 months ago by FDA commissioner Dr. Marty Makary and the director of the FDA’s Center for Biologics Evaluation and Research (CBER) Vinay Prasad MD MPH, in which top industry leaders and scientists shared their views about how to accelerate the R&D process and innovation in the 🇺🇸 BioTech and Pharma ecosystem. It is great to see that this important meeting bore fruit and helped not only to shape the future of the American BioTech ecosystem for years to come but also provided huge hope for patients with genetic diseases worldwide!

Yair Einhorn

25,251 görüntüleme • 6 ay önce

Another timelapse view into our beloved International Space Station Lifesciences Glovebox – this time to harvest the stem cells and conclude the experiment (May 28 post). This goal of this experiment was to produce stem cells in large numbers, using the innovative microgravity bioreactor seen inside the glovebox. Stem cell therapies provide significant benefits to help patients fight disease or recover from chemotherapy. The scientists behind this experiment hypothesized that space-grown cells may retain the ability to continuously divide for longer than stem cells on Earth, which could create larger supplies of cells crucial to provide therapies for patients back on Earth. Stay tuned, because the initial results appear incredibly promising!

Another timelapse view into our beloved International Space Station Lifesciences Glovebox – this time to harvest the stem cells and conclude the experiment (May 28 post). This goal of this experiment was to produce stem cells in large numbers, using the innovative microgravity bioreactor seen inside the glovebox. Stem cell therapies provide significant benefits to help patients fight disease or recover from chemotherapy. The scientists behind this experiment hypothesized that space-grown cells may retain the ability to continuously divide for longer than stem cells on Earth, which could create larger supplies of cells crucial to provide therapies for patients back on Earth. Stay tuned, because the initial results appear incredibly promising!

Jessica Meir

16,308 görüntüleme • 24 gün önce

Remember Aduhelm? It was Biogen’s $56,000/year Alzheimer’s drug that didn’t even work. Worse, it caused brain swelling, brain bleeding, and sudden falls in patients—and the FDA approved it anyway. But the truth is, you don’t need deep pockets to treat Alzheimer’s. You just need to look at what Big Pharma can’t monetize. Here are the real causes behind Alzheimer’s—and the inexpensive and safe treatment options you can explore instead. 🧵 THREAD

Remember Aduhelm? It was Biogen’s $56,000/year Alzheimer’s drug that didn’t even work. Worse, it caused brain swelling, brain bleeding, and sudden falls in patients—and the FDA approved it anyway. But the truth is, you don’t need deep pockets to treat Alzheimer’s. You just need to look at what Big Pharma can’t monetize. Here are the real causes behind Alzheimer’s—and the inexpensive and safe treatment options you can explore instead. 🧵 THREAD

A Midwestern Doctor

67,042 görüntüleme • 1 ay önce

Dr. Patrick Soon-Shiong just exposed a maddening FDA reality on his own approved cancer drug (Anktiva): It’s fully approved in the US for one rare form of bladder cancer… but not for the common form most patients have. So even though the same drug is already FDA-approved and sitting in their files, he can’t use it off-label for other patients without insane one-patient-at-a-time paperwork, IRB delays, and individual FDA sign-off. Meanwhile, Saudi Arabia (with their own sophisticated FDA) reviewed the exact same 1.7 million pages of data and approved it for more cancers. His blunt takeaway: Cancer is a war against time. Patients are forced to fly to Saudi Arabia for access… or wait in bureaucratic limbo while the clock runs out. “I’m completely befuddled as to why this molecule… that stimulates your NK cells is not allowed to give to people who have low NK cells.” If a drug is already FDA-approved and sitting in their own files, why the insane barriers to using it for other patients who are dying? Is this protecting people… or protecting something else?

Dr. Patrick Soon-Shiong just exposed a maddening FDA reality on his own approved cancer drug (Anktiva): It’s fully approved in the US for one rare form of bladder cancer… but not for the common form most patients have. So even though the same drug is already FDA-approved and sitting in their files, he can’t use it off-label for other patients without insane one-patient-at-a-time paperwork, IRB delays, and individual FDA sign-off. Meanwhile, Saudi Arabia (with their own sophisticated FDA) reviewed the exact same 1.7 million pages of data and approved it for more cancers. His blunt takeaway: Cancer is a war against time. Patients are forced to fly to Saudi Arabia for access… or wait in bureaucratic limbo while the clock runs out. “I’m completely befuddled as to why this molecule… that stimulates your NK cells is not allowed to give to people who have low NK cells.” If a drug is already FDA-approved and sitting in their own files, why the insane barriers to using it for other patients who are dying? Is this protecting people… or protecting something else?

Camus

51,126 görüntüleme • 5 ay önce

This might be the most important 2-minute segment in the history of Huberman Lab "Your experience of life and your level of motivation and drive depends on how much dopamine you have relative to your recent experience." - Andrew D. Huberman, Ph.D. Dopamine is the currency of life

This might be the most important 2-minute segment in the history of Huberman Lab "Your experience of life and your level of motivation and drive depends on how much dopamine you have relative to your recent experience." - Andrew D. Huberman, Ph.D. Dopamine is the currency of life

Huberman Protocols (not Andrew Huberman)

608,511 görüntüleme • 2 yıl önce

"America attracts the best scientists and funds the most science in the world" - "This is the thing that won us the Cold War." "I'm worried that it might stop happening, esp the talent flow between China and the US."

"America attracts the best scientists and funds the most science in the world" - "This is the thing that won us the Cold War." "I'm worried that it might stop happening, esp the talent flow between China and the US."

TBPN

73,493 görüntüleme • 1 yıl önce

#BREAKING It is a big day for the Liver Community! Madrigal is proud to announce the first and only U.S. FDA-approved therapy in NASH/MASH. Learn more here: #FDAApproval #NASH

#BREAKING It is a big day for the Liver Community! Madrigal is proud to announce the first and only U.S. FDA-approved therapy in NASH/MASH. Learn more here: #FDAApproval #NASH

Madrigal Pharmaceuticals

154,005 görüntüleme • 2 yıl önce

Chinese scientists have developed the world’s first iPSC-derived allogeneic cell therapy for drug-resistant epilepsy to win both China NMPA and US FDA clinical trial approvals. Unlike conventional drugs that mainly suppress symptoms, this therapy directly targets the damaged neurons at the root of seizures, repairs neural circuits, and aims for functional reconstruction. The procedure takes about an hour. Patients can usually leave hospital in 5 to 7 days. And the platform may later extend to Parkinson’s, Alzheimer’s, and other neurological disorders. That is not “Made in China,” but medicine rewritten in China. While some countries are still busy weaponizing supply chains, China is building the future of biomedicine.

Chinese scientists have developed the world’s first iPSC-derived allogeneic cell therapy for drug-resistant epilepsy to win both China NMPA and US FDA clinical trial approvals. Unlike conventional drugs that mainly suppress symptoms, this therapy directly targets the damaged neurons at the root of seizures, repairs neural circuits, and aims for functional reconstruction. The procedure takes about an hour. Patients can usually leave hospital in 5 to 7 days. And the platform may later extend to Parkinson’s, Alzheimer’s, and other neurological disorders. That is not “Made in China,” but medicine rewritten in China. While some countries are still busy weaponizing supply chains, China is building the future of biomedicine.

𝘊𝘰𝘳𝘳𝘪𝘯𝘦

12,921 görüntüleme • 3 ay önce

someone connected LIVING BRAIN CELLS to an LLM Cortical Labs grew 200,000 human neurons in a lab and kept them alive on a silicon chip, they taught the neurons to play Pong, then DOOM now someone wired them into a LLM... real brain cells firing electrical impulses to choose every token the AI generates you can see which channels were stimulated, the feedback from the neurons in choosing that letter or word

someone connected LIVING BRAIN CELLS to an LLM Cortical Labs grew 200,000 human neurons in a lab and kept them alive on a silicon chip, they taught the neurons to play Pong, then DOOM now someone wired them into a LLM... real brain cells firing electrical impulses to choose every token the AI generates you can see which channels were stimulated, the feedback from the neurons in choosing that letter or word

chiefofautism

2,962,636 görüntüleme • 4 ay önce

Creating viral content with AI has never been this easy! There are tons of tools out there—ChatGPT, Kling... but the real trick is knowing how to use them! And I’m breaking it all down in this thread 🧵👇

Creating viral content with AI has never been this easy! There are tons of tools out there—ChatGPT, Kling... but the real trick is knowing how to use them! And I’m breaking it all down in this thread 🧵👇

TechHalla

73,397 görüntüleme • 1 yıl önce